Importance Programmed cell death (PD-1) and programmed cell death ligand 1 (PD-L1)
inhibitors have been increasingly used in cancer therapy. Understanding the treatment …

Background Immune checkpoint inhibitors targeting the PD-1/PD-L1 pathway have
demonstrated promise in treating a variety of advanced cancers; however, little is known …

Background: Inhibitors targeting programmed cell death 1 (PD-1) and programmed death-
ligand 1 (PD-L1) have unprecedented effects in cancer treatment. However, the objective …

Background Overall risks of hepatotoxicity with immune checkpoint inhibitors (ICIs) have yet
to be compared in primary liver cancers to other solid tumors. Methods We reviewed data …

The development of chemotherapeutic dug resistance hinders the clinical treatment of
cancer. MicroRNAs (miRNAs/miRs) have been revealed to serve essential roles in the drug …

Simple Summary Immune checkpoint inhibitors are increasingly being used in the treatment
of a variety of cancers, both alone and in combination with other cancer therapies. Side …

The incidence of venous and arterial thromboembolic events in advanced cancer patients
treated with immune checkpoint inhibitors (ICIs) has been sporadically reported. We …

Background: This meta-analysis aimed to explore if immunotherapy or chemotherapy alone
or in combination is a better first line treatment strategy for advanced non-small cell lung …

Background Immune Checkpoint Inhibitors (ICI) have been progressively used in cancer
treatment and produced unique toxicity profiles. This systematic review aims to comprehend …

Immunotherapy, especially immune checkpoint inhibitors, has revolutionized the treatment
of non-small cell lung cancer. However, data on ethnic differences in response to these …